Bay Street News, 2020

-Beta thalassemia: Two patients are transfusion independent at 5 and 15 months after CTX001 infusion; data demonstrate clinical proof-of-concept for […]

Sustained efficacy and safety trends observed for up to 28.6 months support ongoing pivotal Phase 3 trial dosing and endpoints, […]

CAMBRIDGE, Mass. and BEIJING, China, June 12, 2020 (GLOBE NEWSWIRE) — BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biotechnology […]

Pivotal AUTO1 study in adult ALL patients enrolling–  AUTO1 continued favorable safety profile and high level of clinical activity, pivotal […]

Spleen response rates in first-line patients at 12 weeks and 24 weeks in line with previously reported data and differentiated […]

– 5 of 8 (63%) Efficacy Evaluable Patients Achieved a Hemoglobin Increase of ≥1.0 g/dL From Baseline –– Safety Profile […]

BEIJING, June 12, 2020 (GLOBE NEWSWIRE) — Kaixin Auto Holdings (“Kaixin” or the “Company”) (NASDAQ: KXIN), one of the primary […]

TORONTO, June 12, 2020 (GLOBE NEWSWIRE) — Galantas Gold Corporation (the ‘Company’) (TSXV & AIM : Symbol GAL) is pleased […]

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESVANCOUVER, British Columbia, June 12, 2020 […]

Collaboration combines NXP’s automotive quality and functional safety with TSMC’s industry-leading 5nm technology to further drive the transformation of automobiles […]